Meta-analysis of 34 RCTs (7486 patients): paclitaxel-coated femoropopliteal devices were associated with higher long-term all-cause mortality vs control (13.6% vs 11.3% crude; HR 1.18), with excess risk peaking in years 1-2 (HR 1.45).
Meta-analysisn = 7,486
Katsanos et al. Editor's Choice - Dynamic Risk of Death following Application of Paclitaxel Coated Devices in the Femoropopliteal Artery: A Contemporary Meta-analysis of Randomised Controlled Trials